OLEMA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.36 USD | -1.68% |
|
-7.96% | -33.29% |
Chart calendar Olema Pharmaceuticals, Inc.
bbf.AlDATIrDHXNFX1MCchV7QEHJT55Z70qqXws8kr9qASM.LwSSBMXzXAoPMAk2EHlMLimwGfcarCeabjNm84lZYmJuFZApy7deIwYmMA~5949d4db79d57d44ec17d473f942b8f6
Upcoming events on Olema Pharmaceuticals, Inc.
Past events on Olema Pharmaceuticals, Inc.
| 2024-05-20 | UBS Spring Biotech Symposium |
| 2024-05-20 04:00 pm | H.C. Wainwright BioConnect Investor Conference - Fireside Chat |
| 2024-05-16 06:00 am | ESMO Breast Cancer Congress - Poster Presentation #212P |
| 2024-05-15 08:00 am | ESMO Breast Cancer Congress |
| 2024-05-14 07:35 pm | BofA Securities Health Care Conference |
| 2024-05-08 04:02 pm | Q1 2024 Earnings Release |
| 2024-04-15 02:00 pm | CG Horizons in Oncology Virtual Conference - Panel |
| 2024-03-11 | Jefferies Biotech on the Bay Summit |
| 2024-03-11 04:03 pm | Q4 2023 Earnings Release |
| 2024-03-06 09:10 am | TD Cowen Health Care Conference - Panel |
| 2024-02-13 10:40 am | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-09 08:15 pm | JPMorgan Healthcare Conference |
| 2023-12-07 06:30 pm | San Antonio Breast Cancer Symposium - PS15-04 |
| 2023-12-07 06:00 pm | San Antonio Breast Cancer Symposium - PO4-04-12 |
| 2023-12-07 01:00 pm | San Antonio Breast Cancer Symposium - PO3-18-09 |
| 2023-12-06 08:00 am | Business Update Call |
| 2023-11-29 01:20 pm | Evercore ISI HealthCONx Conference |
| 2023-11-15 07:30 am | Jefferies London Healthcare Conference |
| 2023-11-07 04:02 pm | Q3 2023 Earnings Release |
| 2023-10-23 08:00 am | European Society for Medical Oncology Congress |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -21,5 -16,9 -27.34% | -71,3 -71,0 -0.46% | -107 -124 14.01% | -105 -98,8 -5.83% | -135 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -21,5 -18,5 -16.58% | -71,5 -67,2 -6.42% | -107 -106 -0.77% | -105 -100 -4.78% | -138 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -22,1 -19,9 -11.44% | -71,1 -66,8 -6.37% | -105 -105 -0.26% | -96,7 -94,1 -2.73% | -134 |
|
Net income Million USD | Released Forecast Spread | -4,32 | -24,0 -19,1 -25.84% | -71,1 -66,8 -6.37% | -105 -105 0.02% | -96,7 -94,0 -2.78% | -134 |
|
EPS USD | Released Forecast Spread | -0,60 | -3,42 -1,01 -237.85% | -1,80 -1,68 -7.14% | -2,62 -2,67 1.92% | -2,14 -2,12 -1.1% | -2,40 |
| Announcement Date | 30/10/20 | 17/03/21 | 28/02/22 | 09/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -23,2 -26,0 10.88% | -33,2 -28,0 -18.6% | -23,1 -35,0 33.91% | -27,1 -24,0 -13.01% | -29,5 -28,0 -5.36% | -21,5 -30,0 28.33% | -23,3 -22,0 -5.69% | -30,3 -24,2 -25.33% | -34,3 -31,9 -7.25% | -34,0 | -35,9 | -39,3 | ||
|
EBIT Million USD | Released Forecast Spread | -23,3 -23,2 -0.34% | -33,3 -26,5 -25.87% | -23,2 -31,0 25.14% | -27,2 -26,3 -3.49% | -29,6 -27,1 -9.09% | -21,6 -30,0 28.09% | -23,3 -23,1 -0.95% | -30,4 -25,6 -18.77% | -34,3 -31,3 -9.58% | -33,3 | -34,9 | -37,0 | -34,1 | -38,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,0 -22,9 -0.57% | -32,9 -26,2 -25.65% | -22,7 -30,9 26.57% | -26,2 -26,0 -0.53% | -28,3 -26,8 -5.39% | -20,1 -29,4 31.6% | -21,5 -21,7 1.13% | -26,8 -24,2 -10.67% | -31,0 -29,9 -3.64% | -32,6 | -34,2 | -36,7 | -35,0 | -38,0 |
|
Net income Million USD | Released Forecast Spread | -23,0 -22,9 -0.57% | -32,9 -26,2 -25.65% | -22,7 -30,9 26.57% | -26,2 -26,0 -0.53% | -28,3 -26,8 -5.39% | -20,1 -29,8 32.63% | -21,5 -21,7 1.13% | -26,8 -24,2 -10.67% | -31,0 -29,9 -3.64% | -32,6 | -34,2 | -36,7 | -35,0 | -38,0 |
|
EPS USD | Released Forecast Spread | -0,58 -0,57 -1.8% | -0,82 -0,64 -27.55% | -0,57 -0,77 25.88% | -0,65 -0,65 0.4% | -0,70 -0,66 -5.6% | -0,49 -0,74 33.62% | -0,48 -0,51 6.18% | -0,49 -0,48 -1.98% | -0,56 -0,54 -2.96% | -0,58 | -0,60 | -0,65 | -0,60 | -0,65 |
| Announcement Date | 09/05/22 | 09/08/22 | 08/11/22 | 09/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 11/03/24 | 08/05/24 | - | - | - | - | - |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Olema Pharmaceuticals, Inc.
| Today | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| Today | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OLMA Stock
- Calendar Olema Pharmaceuticals, Inc.